FUNI on OTC
Hypha Labs, Inc.
American testing laboratories services company, incorporated in Nevada. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with 20/20 Biolabs, Inc., NeoGenomics or UL Solutions Inc., or pick any stock.
- TickerFUNI on OTC1
- IndustryServices-Testing Laboratories1
- HeadquartersLas Vegas, Nevada1
- Incorporated inNV2
- Business address5940 S. Rainbow Boulevard, Las Vegas, Nv 891182
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
February 20, 2024, we completed the sale of the net assets of our wholly owned subsidiary Digipath Labs, Inc. (“Digipath Labs”).3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
39.5%Gross margin4
-42.6%Operating margin5
-76.2%Net margin5
7.8%Revenue growth, 20224
-$202.5KFree cash flow5
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue61¢$1.6M
- Other costs30¢$821.4K
- Interest9¢$244.6K
Out of $2.7M in revenue.45 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.10
| Period ending | 2025-09-30 | 2024-09-30 |
|---|---|---|
| General and administrative | $1.4M | $943.7K |
| Professional fees | $1.6M | $883.3K |
| Total operating expenses | $3.0M | $1.8M |
| Operating loss | -$3.0M | -$1.8M |
| Interest expense | -$106.1K | -$201.8K |
| Other income (expense) | -$20.0K | $13.9K |
| Recovery of previously written off receivables | $58.0K | $66.0K |
| Loss on extinguishment of debt | -$32.3K | -$956.5K |
| Gain on sale of subsidiary assets | $1.5M | |
| Total other income (expense) | -$100.5K | $470.6K |
| Net loss from continuing operations before income taxes | -$3.1M | -$1.4M |
| Income tax expense | -$14.2K | |
| Net loss from continuing operations | -$3.1M | -$1.4M |
| Net income from discontinued operations | $585.2K | |
| Net income (loss) | -$3.1M | -$785.4K |
| Net loss per share from continuing operations - basic | -$0 | -$0 |
| Net loss per share from continuing operations - fully diluted | -$0 | -$0 |
| Net income per share from discontinued operations - basic | $0 | |
| Net income per share from discontinued operations - fully diluted | $0 | |
| Net loss per share basic | -$0.02 | -$0.01 |
| Net loss per share fully diluted | -$0.02 | -$0.01 |
| Weighted average number of common shares outstanding - basic | 135.1M shares | 101.3M shares |
| Weighted average number of common shares outstanding - fully diluted | 135.1M shares | 101.3M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.10
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|
| Cash | $38.1K | $91.2K | |
| Prepaids and other current assets | $26.6K | $289.0K | |
| Deferred offering costs | $255.9K | $30.0K | |
| Total current assets | $320.5K | $410.2K | |
| Fixed assets, net | $62.5K | $26.6K | |
| Right-of-use asset | $26.2K | $57.0K | |
| Total non-current assets | $88.7K | $83.6K | |
| Total Assets | $409.2K | $493.8K | |
| Accounts payable | $472.6K | $86.3K | |
| Current maturities of notes payable | $315.7K | ||
| Current maturities of convertible notes payable, net of discounts | $1.3M | $1.1M | |
| Lease liabilities - current | $26.8K | $36.4K | |
| Total current liabilities | $2.5M | $1.4M | |
| Lease liabilities long term | $26.8K | ||
| Total non-current liabilities | $26.8K | ||
| Total Liabilities | $2.5M | $1.4M | |
| Series B convertible preferred stock, $0.001 par value, 1,500,000 shares authorized; 333,600 shares issued and outstanding as of September 30, 2025 and 2024 | $333.6K | $333.6K | |
| Common stock, $0.001 par value, 880,000,000 shares authorized; 147,121,825 and 123,046,825 shares issued and outstanding as of September 30, 2025 and 2024, respectively | $147.1K | $123.0K | |
| Additional paid-in capital | $21.1M | $19.2M | |
| Accumulated deficit | -$23.6M | -$20.5M | |
| Total Stockholders Deficit | -$2.4M | -$1.3M | -$2.2M |
| Total Liabilities and Stockholders Deficit | $409.2K | $493.8K | |
| Preferred stock, par value | $0.00 | ||
| Preferred stock, shares authorized | 70.0M shares | ||
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 880.0M shares | 880.0M shares | |
| Common stock, shares issued | 147.1M shares | 123.0M shares | |
| Common stock, shares outstanding | 147.1M shares | 123.0M shares |
| Period ending | 2025-09-30 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|
| Cash | $38.1K | $91.2K | |
| Prepaids and other current assets | $26.6K | $289.0K | |
| Deferred offering costs | $255.9K | $30.0K | |
| Total current assets | $320.5K | $410.2K | |
| Fixed assets, net | $62.5K | $26.6K | |
| Right-of-use asset | $26.2K | $57.0K | |
| Total non-current assets | $88.7K | $83.6K | |
| Total Assets | $409.2K | $493.8K | |
| Accounts payable | $472.6K | $86.3K | |
| Current maturities of notes payable | $315.7K | ||
| Current maturities of convertible notes payable, net of discounts | $1.3M | $1.1M | |
| Lease liabilities - current | $26.8K | $36.4K | |
| Total current liabilities | $2.5M | $1.4M | |
| Lease liabilities long term | $26.8K | ||
| Total non-current liabilities | $26.8K | ||
| Total Liabilities | $2.5M | $1.4M | |
| Series B convertible preferred stock, $0.001 par value, 1,500,000 shares authorized; 333,600 shares issued and outstanding as of September 30, 2025 and 2024 | $333.6K | $333.6K | |
| Common stock, $0.001 par value, 880,000,000 shares authorized; 147,121,825 and 123,046,825 shares issued and outstanding as of September 30, 2025 and 2024, respectively | $147.1K | $123.0K | |
| Additional paid-in capital | $21.1M | $19.2M | |
| Accumulated deficit | -$23.6M | -$20.5M | |
| Total Stockholders Deficit | -$2.4M | -$1.3M | -$2.2M |
| Total Liabilities and Stockholders Deficit | $409.2K | $493.8K | |
| Preferred stock, par value | $0.00 | ||
| Preferred stock, shares authorized | 70.0M shares | ||
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 880.0M shares | 880.0M shares | |
| Common stock, shares issued | 147.1M shares | 123.0M shares | |
| Common stock, shares outstanding | 147.1M shares | 123.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.10
| Period ending | 2025-09-30 | 2024-09-30 |
|---|---|---|
| Net loss from continuing operations | -$3.1M | -$1.4M |
| Depreciation expense | $10.8K | $1.0K |
| Gain on sale of subsidiary assets | -$1.5M | |
| Stock-based compensation | $1.9M | $733.7K |
| Amortization of debt discounts | $2.1K | $43.0K |
| Amortization of right-of-use asset | $30.8K | $17.6K |
| Loss on debt extinguishment | $32.3K | $956.5K |
| Other current assets | $262.5K | -$60.5K |
| Accounts payable | $368.8K | -$30.3K |
| Accrued expenses | $96.3K | -$136.2K |
| Accrued expenses related parties | $104.5K | $13.5K |
| Lease liability | -$36.4K | -$11.3K |
| Net cash (used in) operating activities from continuing operations | -$380.0K | -$1.4M |
| Net cash provided by operating activities from discontinued operations | $358.6K | |
| Net cash provided by (used in) operating activities | -$380.0K | -$1.0M |
| Purchase of fixed assets | -$33.0K | -$27.7K |
| Proceeds from sale of subsidiary net assets | $2.2M | |
| Net cash (used) in investing activities from continuing operations | -$33.0K | $2.1M |
| Net cash (used) in investing activities | -$33.0K | $2.1M |
| Repayments of notes payable | -$596.0K | |
| Proceeds from notes payable | $197.2K | |
| Repayments on convertible notes | -$650.0K | |
| Proceeds from convertible notes | $193.0K | |
| Payments of deferred offering costs | -$106.7K | -$30.0K |
| Proceeds from sales of Series D Preferred shares | $76.3K | |
| Proceeds from sales of Series C Preferred shares | $100 | |
| Net cash provided by (used in) financing activities | $359.9K | -$1.3M |
| Net cash used in financing activities from discontinued operations | -$15.8K | |
| Net cash provided by (used in) financing activities | $359.9K | -$1.3M |
| Net increase (decrease) in cash | -$53.0K | -$179.8K |
| Interest paid | $266.5K | |
| Addition of accounts payable and accrued interest into note payable | $116.6K | $31.0K |
| Deferred offering costs accrued and unpaid | $120.2K | |
| Amortization of deferred offering costs | $1.1K | |
| Initial right-of-use asset valuation | $74.6K | |
| Common stock issued for conversion of note payable | $40.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Hypha Labs, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
201520202025
- Chief executive officerA. Stone Douglass Dec 2, 2024 to Dec 2, 202412
- Chief executive officerKyle Remenda Oct 3, 2019 to Mar 13, 202013
- Chief executive officerTodd Denkin Jul 6, 2018 to Sep 30, 201914
- Chief executive officerJoseph J. Bianco Jun 23, 2016 to Mar 29, 201815
- Chief executive officerBarbee Denny Barbee Jun 2, 2014 to Jun 2, 201416
- ChairA. Stone Douglass Oct 22, 2021 to Dec 2, 202417
- PresidentA. Stone Douglass Dec 2, 2024 to Dec 2, 202412
- PresidentTodd Denkin Apr 18, 2014 to Jul 6, 202118
- Chief financial officerA. Stone Douglass Oct 22, 2021 to Dec 2, 202417
- Chief financial officerAlfredo Axtmayer Dec 27, 2017 to Dec 27, 201719
- Chief financial officerTodd A. Peterson Jun 23, 2015 to Mar 29, 202120
- Chief financial officerEric Stoppenhagen Apr 21, 2014 to Apr 21, 201421
- Chief operating officerTodd Denkin Jun 23, 2016 to Mar 29, 201822
Board members and other officers (11)
- Board memberA. Stone Douglass Jul 12, 2021 to Jul 12, 202123
- Board memberEdmond Defrank Feb 3, 2020 to Mar 29, 202124
- Board memberDennis Hartmann Oct 3, 2019 to Jun 28, 202125
- Board memberBruce I. Raben Sep 18, 2018 to Jun 28, 202126
- Board memberCindy Sue Orser Sep 18, 2018 to Jan 9, 201927
- Board memberAlfredo Axtmayer Mar 3, 2017 to Dec 27, 201728
- Board memberBarbee Denny Barbee Jan 2, 2015 to Jan 2, 201529
- Board memberJoseph J. Bianco Oct 19, 2015 to Mar 29, 201830
- Board memberTodd Denkin Apr 18, 2014 to Sep 30, 201918
- Board memberEric Stoppenhagen Apr 21, 2014 to Apr 21, 201421
- Board memberJoe D. Tanner Jun 27, 2014 to Jun 27, 201431
Former names
Timeline
- Dec 2, 2024New chief executive A. Stone Douglass becomes CEO12
- Oct 3, 2019New chief executive Kyle Remenda becomes CEO13
- Jul 6, 2018New chief executive Todd Denkin becomes CEO14
- Jun 23, 2016New chief executive Joseph J. Bianco becomes CEO15
- Jun 2, 2014New chief executive Barbee Denny Barbee becomes CEO16
Filings
64 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 12 major events, 2 insider forms, 29 other. The latest 20:
- Aug 14, 202610-Q EDGAR
- May 15, 202610-Q EDGAR
- Feb 17, 202610-Q EDGAR
- Jan 30, 20268-K EDGAR
- Jan 15, 202610-K EDGAR
- Dec 30, 2025NT 10-K EDGAR
- Nov 6, 2025253G2 EDGAR
- Aug 21, 202510-Q EDGAR
- Aug 14, 2025NT 10-Q EDGAR
- Jul 1, 2025253G2 EDGAR
- Jun 30, 2025QUALIF EDGAR
- Jun 26, 2025CORRESP EDGAR
- Jun 26, 20251-A/A EDGAR
- Jun 16, 2025CORRESP EDGAR
- Jun 16, 20251-A/A EDGAR
- Jun 13, 202510-Q EDGAR
- May 15, 2025NT 10-Q EDGAR
- May 1, 2025UPLOAD EDGAR
- Apr 21, 2025CORRESP EDGAR
- Apr 21, 20251-A/A EDGAR
The 64 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARTodd Denkin, Chief executive officer
- 15
- 16
- 17SEC EDGARA. Stone Douglass, Chair
- 18SEC EDGARTodd Denkin, President
- 19
- 20
- 21
- 22SEC EDGARTodd Denkin, Chief operating officer
- 23SEC EDGARA. Stone Douglass, Board member
- 24SEC EDGAREdmond Defrank, Board member
- 25SEC EDGARDennis Hartmann, Board member
- 26SEC EDGARBruce I. Raben, Board member
- 27SEC EDGARCindy Sue Orser, Board member
- 28SEC EDGARAlfredo Axtmayer, Board member
- 29SEC EDGARBarbee Denny Barbee, Board member
- 30SEC EDGARJoseph J. Bianco, Board member
- 31SEC EDGARJoe D. Tanner, Board member